Soleno Therapeutics, Inc. (SLNO)
49.64
-0.31
(-0.62%)
USD |
NASDAQ |
Dec 16, 15:09
Soleno Therapeutics Research and Development Expense (Annual): 78.57M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 303.25M |
| AVITA Medical, Inc. | 20.36M |
| Agilon Health, Inc. | -- |
| Geron Corp. | 103.74M |
| Cassava Sciences, Inc. | 69.64M |